Another limitation of the design of this study is that the mean Hb levels per lesion (non-neoplastic polyp, non-advanced adenoma, advanced adenoma or CRC) only pertain to screenees who had a positive test (faecal Hb level ⩾50 ng ml−1) and subsequently underwent a follow-up colonoscopy. This evidence concerns the gene GSTM1 and polyp.